Since the birth of Google Glass, experts have been looking forward to its future application value in specific areas. Especially in the medical field, many people pay attention to it. Many experts have begun to study its application direction.
Some time ago, the news that Google Glass entered the operating room for the first time made many people see the energy it played in this direction. The on-site real-time live broadcast through glasses allows medical workers to perform more powerfully when performing surgical procedures. When faced with a sudden or difficult operation, doctors can use glasses and medical experts to achieve timely communication, on-site analysis, on-site surgical planning, etc. This application is of great significance for saving patients.
Although researchers are constantly expanding the application direction of wearable devices, the news has also been reported. However, there has not been any relevant information on the professional academic certification or application platform. However, hristian Assad-Kottner and his team changed this situation. They recently published the first paper on the medical application field of wearable device "Google Glass" Google Glass at Health and Technology.
The main research direction of this paper is the application of Google glasses in medical education. The papers show that they have found that the application of Google glasses can greatly improve the quality of medical education, and also provide more security when treating patients.
In China, nervous system drugs are also one of the drugs with the most rapid sales growth in recent years. In 2002, nervous system drugs occupied 5.9% of the entire pharmaceutical market share, and the total sales amount increased by 9.4%.
With the increasing trend of urbanization and aging, the elderly population in China has exceeded 120 million, and the incidence of geriatric diseases, especially mental diseases, is increasing year by year. With the increase of residents' income, the elderly's requirements for quality of life also increase. As a result, the demand for drugs to treat mental illnesses such as Alzheimer's has soared. In WHO drug classification, psychotropic drugs and nootropic drugs are grouped into one class. We briefly analyzed the development trend of this class of drugs through the clinical drug use data collected from more than 300 domestic key hospitals by Chinese Pharmaceutical Association.
The overall market size of this class of drugs is about 1.22 billion yuan, the consumption sum increased by 5.0% in 2002, but the sales quantity increased by 11.2%. The main reason why the consumption sum did not increase with the sales quantity is that several main varieties of this class of drugs, such as piracetam, cobalt bin amide and ginkgo biloba leaf, etc. In 2002, the price of selling units fell sharply due to bidding. Among these drugs, ginkgo biloba preparation occupies the largest market share, accounting for more than 1/3 of the market share, ganglioside ester and cobalt bin amide combined also occupy nearly 1/3 of the market share, piracetam and other "sitan" drugs occupy nearly 10% of the market share, the rest of the drugs occupy less than 5% of the market share. At present, more than 20 ginkgo leaf production enterprises, piracetam production enterprises more than 70, have entered the stage of price competition, profit repeatedly diluted.
In the first-line varieties, except ginkgo biloba leaves preparation maintained vigorous vitality, the growth of other varieties were weak, especially the traditional variety piracetam suffered from bidding
buy nootropics,nootropics benefits,nootropics for adhd,nootropics for weight loss,nootropics supplements
Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptidenootropics.com